Retina and Vitreous Center

Cindy Watson, Study Coordinator

The Retina and Vitreous Center has been involved in clinical research for over ten years, and we remain committed to providing our patients with state of the art medical care.

We are currently seeking subjects for participation in the following clinical trials:

• Wet Macular Degeneration (sponsored by Regeneron)
  A 96-week trial testing the safety and efficacy of repeated doses of Intravitreal VEGF Trap compared with Lucentis treatments administered every four weeks. For more information about this clinical trial, please visit www.clinicaltrials.gov and search for NCT00509795.



---


Kelli Shaffar, Study Coordinator Assistant


• Wet Macular Degeneration (sponsored by Ophthotech)
  The objectives of this study are to evaluate the safety, tolerability, and pharmacokinetic profile of volociximab intravitreous injection in subjects with subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD). For more information about this clinical trial, please visit www.clinicaltrials.gov and search for NCT00782093.

For more information about enrollment in our current studies please call Cindy Watson or Kelli Shaffar at (541) 488-3192, or send an e-mail to This e-mail address is being protected from spambots. You need JavaScript enabled to view it .